MediWound (NASDAQ:MDWD – Get Free Report) will release its earnings data before the market opens on Tuesday, November 26th. Analysts expect MediWound to post earnings of ($0.48) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
MediWound Stock Down 1.7 %
Shares of NASDAQ MDWD opened at $16.48 on Monday. The company’s fifty day moving average is $17.21 and its 200-day moving average is $17.39. The stock has a market cap of $177.82 million, a price-to-earnings ratio of -7.63 and a beta of 0.83. MediWound has a twelve month low of $8.41 and a twelve month high of $24.00.
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. HC Wainwright reiterated a “buy” rating and issued a $28.00 price objective on shares of MediWound in a research report on Friday, October 11th. StockNews.com upgraded shares of MediWound to a “sell” rating in a report on Monday, August 5th.
About MediWound
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
Read More
- Five stocks we like better than MediWound
- Golden Cross Stocks: Pattern, Examples and Charts
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Are Penny Stocks a Good Fit for Your Portfolio?
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Investing In Preferred Stock vs. Common Stock
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for MediWound Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediWound and related companies with MarketBeat.com's FREE daily email newsletter.
